Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin

  • Albrecht Fiesselmann, Tobias Wiesner, Holger Fleischmann, Peter Bramlage
  • Acta Diabetologica, April 2016, Springer Science + Business Media
  • DOI: 10.1007/s00592-016-0862-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00592-016-0862-0

The following have contributed to this page: Peter Bramlage